« Back to Record
Bardia, A., Tolaney, S. S., Punie, K., Loirat, D., Oliveira, M., Kalinsky, K., Zelnak, A. A., Aftimos, P., Dalenc, F., Sardesai, S. S., Hamilton, E., Sharma, P., Recalde, S., Gil, E., Traina, T. T., O'Shaughnessy, J., Cortes, J., Tsai, M. H., Vahdat, L. L., Diéras, V., Carey, L. L., Rugo, H. H., Goldenberg, D. D., Hong, Q. Q., Olivo, M. M., Itri, L. M., & Hurvitz, S. (2021). Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. Annals of oncology. doi:10.1016/j.annonc.2021.06.002
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/329200



